February 16-18, 2020

Hard Rock Guitar Hotel & Casino in Hollywood, Florida

Noble Capital Markets' 16th annual emerging growth investor conference provides a forum where private and publicly traded emerging growth companies with less than $2 billion in market capitalization can connect with the investment community, fund managers and high-net-worth investors who focus on small and microcap equities. Taking place at the guitar-shaped Hard Rock Hotel & Casino in Hollywood, Fla., the two-day conference broadens access to investors worldwide by also hosting the conference on NobleCon16 will include presentations by approximately 125 public companies, expert panels moderated by industry leaders, and the opportunity for investors to meet and network with management of presenting companies on a one-on-one basis. Among the lineup of world-class keynote speakers scheduled for this year's conference are Jeb Bush, the 43rd governor of the state of Florida, and Ari Fleisher, White House press secretary for former President George W. Bush. NobleCon16 also provides networking opportunities through social activities and special events. For more information visit

Conference Dates: February 17 February 18


Progressive Care Inc. (OTCQB: RXMD)

Progressive Care (OTCQB: RXMD), through its subsidiaries, is a Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management. Progressive Care seeks to define a new level of service and health care that is driven by the needs of patients and families. As the health care system changes and adjusts, gaps form in the delivery of care leaving patients, providers, and even payors behind to deal with negative health outcomes. Progressive Care works to eliminate these gaps in access to adequate health care and patient therapy management to improve efficacy of the health care system. For more information, visit the company's website at

Charles River Associates (NASDAQ: CRAI)

Charles River Associates® ("CRA") (NASDAQ: CRAI) is a leading global consulting firm specializing in economic, financial and management consulting services. CRA advises clients on economic and financial matters pertaining to litigation and regulatory proceedings, and guides corporations through critical business strategy and performance-related issues. Since 1965, clients have engaged CRA for its unique combination of functional expertise and industry knowledge, and for its objective solutions to complex problems. Headquartered in Boston, CRA has offices throughout the world. For more information, visit the company's website at

Empire Diversified Energy Inc. (OTCQB: MPIR)

Empire Diversified Energy (OTCQB: MPIR) is a full-service firm offering solutions to the dynamic changing needs of the energy industry. The company's goal, based on years of demonstrable experience, is to offer strategic and innovative on-site execution in addressing industry issues such as remediation of Coal Combustion Residue (CCR) and the development of renewable energy sources. Empire Diversified seeks to acquire, invest and expand several energy transportation facilities throughout the Midwest, and has entered into binding agreements to acquire a majority equity interest in Trimodal Terminal and GoGreen American Recycling in Weirton, WV. For more information, visit the company's website at


Sierra Metals Inc. (TSX: SMT) (BVL: SMT) (NYSE: SMTS)

Sierra Metals (TSX: SMT) (BVL: SMT) (NYSE: SMTS) is Canadian-based growing polymetallic mining company with production from its Yauricocha Mine in Peru, and its Bolivar and Cusi Mines in Mexico. The company is focused on increasing production volume and growing mineral resources. Sierra Metals recently had several new discoveries and still has additional brownfield exploration opportunities at all three Mines in Peru and Mexico that are within or close proximity to the existing mines. Additionally, the company has large land packages at all three mines with several prospective regional targets providing longer term exploration upside and mineral resource growth potential. For more information, visit the company's website at

Gray Television Inc. (NYSE: GTN)

Gray Television (NYSE: GTN) currently owns and/or operates television stations and leading digital properties in 93 television markets, including the No. 1 rated television station in 68 markets and the first or second highest rated television station in 87 markets. Gray's television stations cover approximately 24% of U.S. television households and broadcast over 400 separate programming streams, including approximately 150 affiliates of the CBS/NBC/ABC/FOX networks. Gray also owns video program production, marketing, and digital businesses including Raycom Sports, Tupelo-Raycom, and RTM Studios, the producer of PowerNation programs and content. For more information, visit the company's website at

Gevo Inc. (NASDAQ: GEVO)

Gevo (NASDAQ: GEVO) is commercializing the next generation of gasoline, jet fuel and diesel fuel with the potential to achieve zero carbon emissions. Gevo uses low-carbon renewable resource-based carbohydrates as raw materials and is in an advanced state of developing renewable electricity and renewable natural gas for use in production processes, resulting in low-carbon fuels with substantially reduced carbon intensity. Gevo's products perform as well or better than traditional fossil-based fuels in infrastructure and engines, but with substantially reduced greenhouse gas emissions. Gevo's technology also enables certain plastics, such as polyester, to be made with more sustainable ingredients. Gevo's ability to penetrate the growing low-carbon fuels market depends on the price of oil and the value of abating carbon emissions that would otherwise increase greenhouse gas emissions. For more information, visit the company's website at


Orion Group Holdings Inc. (NYSE: ORN)

Orion Group Holdings (NYSE: ORN) is a leading specialty construction company serving the infrastructure, industrial and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin. The company's marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design and specialty services. Its concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar, and mesh across the light commercial, structural and other associated business areas. Orion Group is headquartered in Houston, Texas, with regional offices throughout its operating areas. For more information, visit the company's website at

AgEagle Aerial Systems Inc. (NYSE: UAVS)

AgEagle Aerial Systems (NYSE: UAVS) is recognized as an industry-leading pioneer of technologically advanced aerial imagery-based data collection and analytics solutions. The company helps growers, consumer packaged goods companies and their supply chain partners, and urban green managers proactively assess and manage the health of commercial crops and green infrastructure; reduce the chemicals in produced foods and products; and preserve and protect natural resources. In addition, AgEagle provides to state and territorial departments of agriculture, growers and processors registration, oversight, compliance/enforcement and reporting solutions relating to the United States' emerging hemp cultivation industry. For more information, visit the company's website at


Cocrystal Pharma Inc. (NASDAQ: COCP)

Cocrystal Pharma (NASDAQ: COCP) is a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses and noroviruses. The company is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor currently being evaluated in a phase 2a study for the treatment of hepatitis C as part of a cocktail for ultra-short therapy of four to six weeks. Cocrystal recently entered into an exclusive worldwide license and collaboration agreement with Merck & Co., Inc. to discover and develop certain proprietary influenza A/B antiviral agents. CC-42344, the company's molecule for the treatment of influenza A, is currently being evaluated in preclinical IND-enabling studies. In addition, the company has a pipeline of promising early discovery program to identify and develop novel antivirals for the treatment of norovirus gastroenteritis. For more information, visit the company's website at

Caladrius Biosciences Inc. (NASDAQ: CLBS)

Caladrius Biosciences (NASDAQ: CLBS) is a late-stage therapeutics development biopharmaceutical company pioneering advancements of cell therapies for select cardiovascular and autoimmune diseases. The company's current product candidates include three developmental treatments for cardiovascular diseases based on its CD34+ cell therapy platform: CLBS12, recipient of a SAKIGAKE designation in Japan and advanced therapy medicinal product classification (ATMP) in Europe, eligible for early conditional approval for the treatment of critical limb ischemia in Japan based on an ongoing clinical trial; CLBS16, subject of the proof-of-concept ESCaPE-CMD clinical trial in the U.S. for the treatment of coronary microvascular dysfunction; and CLBS14, a phase 3 ready clinical program in no option refractory disabling angina and recipient of a RMAT designation in the U.S. For more information, visit the company's website at

Energy Fuels Inc. (NYSE: UUUU)

Energy Fuels (NYSE: UUUU) is a leading U.S.-based uranium mining company supplying U3O8 to major nuclear utilities. The company also produces vanadium from certain of its projects, as market conditions warrant. Energy Fuels holds three of America's key uranium production centers: the White Mesa Mill in Utah, the only conventional uranium mill operating in the U.S., which has a licensed capacity of over 8 million pounds of U3O8 per year and has the ability to produce vanadium when market conditions warrant; the Nichols Ranch in-situ recovery ("ISR") Project in Wyoming, which has a licensed capacity of 2 million pounds of U3O8 per year; and the Alta Mesa ISR Project, which is currently on standby. In addition to the above production facilities, Energy Fuels also has one of the largest NI 43-101 compliant uranium resource portfolios in the U.S. and several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. For more information, visit the company's website at

Comtech Telecommunications Corp. (NASDAQ: CMTL)

Comtech Telecommunications (NASDAQ: CMTL) specializes in system design, integration, supply and commissioning of turnkey communication systems, including over-the-horizon microwave, line-of-sight microwave and satellite. Comtech Telecommunications designs, develops, produces and markets innovative products, systems and services for advanced communications solutions. The company sells products to a diverse customer base in the global commercial and government communications markets. For more information, visit the company's website at


PDS Biotechnology Corp. (NASDAQ: PDSB)

PDS Biotechnology (NASDAQ: PDSB) is developing multiple therapies based on the Versamune® platform, which has been designed to help the body better recognize, attack and destroy cancer. When combined with Versamune®, the body's immune system produces antigen-specific T-cells in response to the treatment to fight and kill the cancer. The company's lead candidate, PDS0101, combines the utility of the Versamune® platform with targeted antigens in HPV-expressing cancers. In partnership with Merck and the National Cancer Institute (NCI), PDS Biotechnology is advancing PD0101 to phase 2 studies in head and neck cancer and in HPV-related advanced cancer. For more information, visit the company's website at

Abacus Health Products Inc. (CSE: ABCS) (OTCQX: ABAHF)

Abacus Health Products (CSE: ABCS) (OTCQX: ABAHF) is engaged in the development and commercialization of over-the-counter (OTC) topical medications with active pharmaceutical ingredients. Abacus' products contain organic and natural ingredients, including hemp extract or oil containing CBD from Cannabis Sativa L. plant. Abacus' products are aimed at the rapidly growing markets for topical pain relief and therapeutic skincare and are based on proprietary patent-pending formulations to provide safe and effective relief. Abacus currently offers two lines of products: CBD CLINIC™, marketed to the professional practitioner market; and CBDMEDIC™, marketed to the consumer market. Abacus' products are offered across the United States and are produced by a contract manufacturer in an FDA-registered and audited manufacturing facility. For more information, visit the company's website at

Ballard Power Systems Inc. (TSX: BLDP) (NASDAQ: BLDP)

Ballard Power Systems' (TSX: BLDP) (NASDAQ: BLDP) vision is to deliver fuel cell power for a sustainable planet. The company's zero-emission PEM fuel cells are enabling electrification of mobility, including buses, commercial trucks, trains, marine vessels, passenger cars, forklift trucks and UAVs. Its technology solutions include product development, systems design and integration, component design and manufacturing, testing services and stations, and licensing and technology transfer. For more information, visit the company's website at

Cornerstone Capital Resources Inc. (TSXV: CGP) (OTC: CTNXF)

is a mineral exploration company with a diversified portfolio of gold, silver and copper projects in Ecuador and Chile, including: a 15% carried interest in the Cascabel copper-gold discovery in Ecuador, financed through to a completion of a bankable feasibility study (plus 8.5% of JV partner SolGold for a total 22.2% interest); and a joint venture with Ecuadorian state mining company ENAMI EP where Cornerstone is exploring nine highly prospective concessions in the vicinity of Cascabel. For more information, visit


Assure Holdings Corp. (TSXV: IOM) (OTCQB: ARHH)

Assure Holdings (TSXV: IOM) (OTCQB: ARHH) works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries. Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles 100% of intraoperative neuromonitoring scheduling and setup, and bills for all technical services provided. Assure Neuromonitoring is recognized as providing the highest level of patient care in the industry and has earned the Joint Commission's Gold Seal of Approval®. For more information, visit the company's website at

Duos Technologies Group Inc. (NASDAQ: DUOT)

Duos Technologies Group (NASDAQ: DUOT), through its wholly owned subsidiary, Duos Technologies Inc., provides advanced analytical technology solutions with a strong portfolio of intellectual property. The company's core competencies include intelligent technologies that combine machine learning, artificial intelligence, and advanced video analytics that are delivered through its proprietary integrated enterprise command and control centraco® platform. Duos Technologies provides its broad range of technology solutions with an emphasis on mission critical security, inspection and operations within the rail transportation, retail, petrochemical, government, and banking sectors. Duos Technologies also offers professional and consulting services for large data centers. For more information, visit the company's website at

InPlay Oil Corp. (TSX: IPO) (OTCQX: IPOOF)

InPlay Oil (TSX: IPO) (OTCQX: IPOOF) is engaged in the business of exploring for, developing and producing oil and natural gas, and acquiring oil and natural gas properties in western Canada. InPlay has concentrated on exploration and development drilling of light oil prospects in the Province of Alberta in a focused area of Central and West Central Alberta. The InPlay management team has an established track record of delivering cost-effective per share growth in reserves, production, AFF and funds flow. The company will continue to implement its proven strategy of exploring, acquiring and exploiting assets with a long-term focus on large, light oil resources. For more information, visit the company's website at

Pyxis Tankers Inc. (NASDAQ: PXS)

Pyxis Tankers (NASDAQ: PXS) currently owns a modern fleet of five tankers engaged in seaborne transportation of refined petroleum products and other bulk liquids. The company is focused on growing its fleet of medium range product tankers, which provide operational flexibility and enhanced earnings potential due to their "eco" features and modifications. Pyxis Tankers is positioned to opportunistically expand and maximize its fleet due to competitive cost structure, strong customer relationships, and an experienced management team whose interests are aligned with those of its shareholders. For more information, visit the company's website at


Hoth Therapeutics Inc. (NASDAQ: HOTH)

Hoth Therapeutics (NASDAQ: HOTH) is a clinical-stage biopharmaceutical company focused on developing new generation therapies for dermatological disorders. HOTH's pipeline has the potential to improve the quality of life for patients suffering from indications including atopic dermatitis, chronic wounds, psoriasis and acne. HOTH has the exclusive worldwide rights to BioLexa, the company's proprietary lead drug candidate topical platform that uniquely combines two FDA-approved compounds to fight bacterial infections across multiple indications. HOTH is preparing to launch its clinical trial for the treatment of adolescent subjects between the ages of two and 17 years, with mild to moderate atopic dermatitis during 2020. For more information, visit the company's website at

Materion Corp. (NYSE: MTRN)

Materion (NYSE: MTRN) is a high-performance advanced materials supplier to global markets, operating through wholly owned subsidiaries. The company's unique product portfolio includes high performance alloys, beryllium products, clad metal strip, composite metals, ceramics, inorganic chemicals, microelectronics packaging materials, precision optics, thin film coatings and thin film deposition materials. Founded in 1931 and headquartered in Cleveland, Ohio, Materion has 32 locations worldwide and a global reach of over 50 countries served. For more information, visit the company's website at

Avino Silver & Gold Mines Ltd. (TSX: ASM) (NYSE: ASM) (GV6: FSE)

Avino Silver & Gold Mines (TSX: ASM) (NYSE: ASM) (GV6: FSE) is a silver and gold producer with a diversified pipeline of gold, silver and base metals properties. Avino produces from its wholly owned Avino Mine near Durango, Mexico. The company's gold and silver production remains unhedged. Avino's mission and strategy are to create shareholder value through its focus on profitable organic growth at the historic Avino Property near Durango, Mexico, and the strategic acquisition of mineral exploration and mining properties. For more information, visit the company's website at

Capstone Turbine Corp. (NASDAQ: CPST)

Capstone Turbine (NASDAQ: CPST) is the world's leading producer of low-emission microturbine systems and was the first to market commercially viable microturbine energy products. Capstone has shipped over 9,000 Capstone Microturbine systems to customers worldwide. These award-winning systems have logged millions of documented runtime operating hours. Capstone is a member of the U.S. Environmental Protection Agency's Combined Heat and Power Partnership, which is committed to improving the efficiency of the nation's energy infrastructure and reducing emissions of pollutants and greenhouse gases. A DQS-Certified ISO 9001:2015 and ISO 14001:2015 certified company, Capstone is headquartered in the Los Angeles area with sales and/or service centers in the United States, Latin America, Europe, Middle East and Asia. For more information, visit the company's website at


Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)

Tonix Pharmaceuticals Holding (NASDAQ: TNXP) is a clinical-stage biopharmaceutical company focused on discovering and developing small molecules and biologics to treat psychiatric, pain and addiction conditions. Tonix's lead product candidate, TNX-102 SL (the FDA has conditionally accepted "Tonmya" as the proposed trade name for TNX-102 SL for the treatment of PTSD), is in phase 3 development as a bedtime treatment for PTSD and fibromyalgia, and has received FDA Breakthrough Therapy Designation for PTSD. TNX-102 SL is also in development for agitation in Alzheimer's disease and alcohol use disorder (AUD). The company is also developing TNX-601 as a daytime treatment for PTSD and depression; TNX-1600 for daytime treatment of PTSD; TNX-1300, which is in phase 2 development for the treatment of cocaine intoxication and has FDA Breakthrough Therapy Designation. Tonix's preclinical pipeline includes TNX-1500, developed to prevent and treat organ transplant rejection and autoimmune conditions; TNX-1700, being developed to treat gastric and pancreatic cancers; TNX-801 to potentially prevent smallpox; and TNX-701 to prevent radiation effects are being advanced as medical countermeasures to improve biodefense. For more information, visit the company's website at

Lightwave Logic Inc. (OTCQB: LWLG)

Lightwave Logic (OTCQB: LWLG) is developing a platform leveraging its proprietary engineered electro-optic (EO) polymers to transmit data at higher speeds with less power. The company's high-activity and high-stability organic polymers allow Lightwave Logic to create next-generation photonic EO devices, which convert data from electrical signals into optical signals, for applications in data communications and telecommunications markets. Lightwave Logic's target customer base is the optical datacom and telecom hardware suppliers that interconnect the vast pools of data residing with cloud providers, communications providers, enterprises and governments. For more information, visit the company's website at

Comstock Mining Inc. (NYSE: LODE)

Comstock Mining (NYSE: LODE) is a Nevada-based, gold and silver mining company with extensive, contiguous property in the Comstock District. An emerging leader in sustainable, responsible mining, Comstock is currently commercializing environment-enhancing, precious-metal-based technologies, products and processes for precious metal recovery. Since its first acquisition of property in the Comstock District in 2003, Comstock has consolidated a significant portion of the Comstock District, amassed the single largest known repository of historical and current geological data on the Comstock region, secured permits, built an infrastructure and completed its first phase of production. The company continues evaluating and acquiring properties inside and outside the district expanding its footprint and exploring all of its existing and prospective opportunities for further exploration, development and mining. For more information, visit the company's website at

Pangaea Logistics Solutions Ltd. (NASDAQ: PANL)

Pangaea Logistics Solutions (NASDAQ: PANL) provides logistics services to a broad base of industrial customers who require the transportation of a wide variety of dry bulk cargoes, including grains, pig iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite and limestone. The company addresses the transportation needs of its customers with a comprehensive set of services and activities, including cargo loading, cargo discharge, vessel chartering and voyage planning. The company operates a fleet of approximately 45-60 Supramax, Panamax and Handymax vessels, of which 21 are owned or partially owned. Pangaea Logistics is a leader in the high ice class sector, secured by its control of a majority of the world's large dry bulk vessels with Ice-Class 1a designation. For more information, visit the company's website at


Exactus Inc. (OTCQB: EXDI)

Exactus Inc. (OTCQB: EXDI) is dedicated to introducing hemp-derived phytocannabinoid products that meet the highest standards of quality and traceability into mainstream consumer markets. The company has made investments in farming and has over 200 acres of cannabinoid-rich hemp in Southwest Oregon. Exactus is introducing a range of consumer brands, such as Green Goddess Extracts(TM), Levor Collection(TM), Phenologie(TM), Paradise CBD(TM) and Exactus(TM). Hemp is a federally legal type of cannabis plant containing less than 0.3% THC (tetrahydrocannabinol), which is the psychoactive component of the cannabis plant. After over 40 years of prohibition, the Agricultural Improvement Act of 2018, known as the 2018 Farm Bill, legalized hemp at the federal level. Hemp production will be regulated by the United States Department of Agriculture (USDA) and the states. As a result, in 2019 hemp was generally removed from the Controlled Substances Act (CSA) and enforcement by the Drug Enforcement Administration (DEA). For more information, visit the company's website at

Sernova Corp. (TSXV: SVA) (OTCQB: SEOVF) (FSE: PSH)

Sernova (TSXV: SVA) (OTCQB: SEOVF) (FSE: PSH) is developing regenerative medicine therapeutic technologies using a medical device and immune protected therapeutic cells (i.e., human donor cells, corrected human cells and stem-cell-derived cells) to improve the treatment and quality of life of people with chronic metabolic diseases such as insulin-dependent diabetes, blood disorders including hemophilia, and other diseases treated through replacement of proteins or hormones missing or in short supply within the body. For more information, visit the company's website at

Sundance Energy Inc. (NASDAQ: SNDE)

Sundance Energy (NASDAQ: SNDE) is an independent energy exploration company focused on the acquisition and development of large, repeatable oil and natural gas resource plays in North America. Sundance Energy is located in Denver, Colorado; current activities are focused in South Texas Eagle Ford Shale, where the company has a 51,903-net acre position. For more information, visit the company's website at

Newrange Gold Corp. (TSXV: NRG) (OTCQB: NRGOF) (Frankfurt:X6C)

Newrange Gold (TSXV:NRG) (OTCQB: NRGOF) (Frankfurt:X6C) is a precious metals exploration and development company focused on near- to intermediate-term production opportunities in favorable jurisdictions including Nevada, Colorado and Ontario. With numerous drill intercepts of near surface oxide gold mineralization to 340 grams gold per metric tonne, the company's flagship Pamlico Project is poised to become a significant new Nevada discovery. Focused on developing shareholder value through exploration and development of key projects, the company is committed to building sustainable value for all stakeholders. For more information, visit the company's website at


Xenetic Biosciences Inc. (NASDAQ: XBIO)

Xenetic Biosciences (NASDAQ: XBIO) is a biopharmaceutical company focused on progressing XCART, a personalized CAR T platform technology engineered to target patient-specific tumor neoantigens. The company is initially advancing cell-based therapeutics targeting the unique B-cell receptor on the surface of an individual patient's malignant tumor cells for the treatment of B-cell lymphomas. XCART has the potential to fuel a robust pipeline of therapeutic assets targeting high-value oncology indications. Additionally, Xenetic is leveraging PolyXen, its proprietary drug delivery platform, by partnering with biotechnology and pharmaceutical companies. PolyXen has demonstrated its ability to improve the half-life and other pharmacological properties of next-generation biologic drugs. The company has an exclusive license agreement with Takeda Pharmaceuticals Co. Ltd. in the field of coagulation disorders and receives royalty payments under this agreement. For more information, visit the company's website at

Lineage Cell Therapeutics Inc. (TASE: LCTX) (NYSE: LCTX)

Lineage Cell Therapeutics (TASE: LCTX) (NYSE: LCTX) is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Using its proprietary cell-based therapy platform and associated development and manufacturing capabilities, Lineage develops and manufactures specialized, terminally differentiated human cells developed either to replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineage's clinical assets include: OpRegen®, in phase I/IIa development for the treatment of dry age-related macular degeneration; OPC1, in phase I/IIa development for the treatment of acute spinal cord injuries; and VAC2, in phase I development for the treatment of non-small cell lung cancer. Lineage is also evaluating potential partnership opportunities for Renevia®, a facial aesthetics product that was recently granted a Conformité Européenne (CE) Mark. For more information, visit the company's website at


ImmunoPrecise Antibodies Ltd. (TSXV: IPA) (OTCQB: IPATF)

ImmunoPrecise (TSXV: IPA) (OTCQB: IPATF) is an international, full-service, therapeutic antibody discovery company offering species agnostic advancements such as the B cell Select™ progressive single-cell interrogation technology and the DeepDisplay™ custom, OmniAb®-based phage libraries, as well as the Abthena™ bispecific program. ImmunoPrecise discovery and development are conducted in Utrecht and Oss, the Netherlands (U-Protein Express and IPA Europe, respectively), and in Victoria, British Columbia (IPA Canada). The company operates globally to offer a continuum of superior antibody services, transforming the face of therapeutic discovery, by decreasing turnaround time and risk, and promoting clinical success. For more information, visit the company's website at

OncoSec Medical Inc. (NASDAQ: ONCS)

OncoSec Medical (NASDAQ: ONCS) is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer. OncoSec has built a deep and diverse clinical pipeline utilizing its primary technology, TAVO™ (tavokinogene telseplasmid), as a potential treatment for multiple cancer indications, either as a monotherapy or in combination with leading checkpoint inhibitors. The latter potentially enables OncoSec to address a great unmet medical need in oncology: anti-PD-1 non- responders. OncoSec is also identifying and developing new DNA-encoded therapeutic candidates and tumor indications for use with its new Visceral Lesion Applicator (VLA), to target deep visceral lesions, such as liver, lung or pancreatic lesions. For more information, visit the company's website at

Summit Wireless Technologies Inc. (NASDAQ: WISA)

Summit Wireless Technologies (NASDAQ: WISA) is a provider of immersive, wireless sound technology for intelligent devices and next generation home entertainment systems. Working with leading CE brands and manufacturers such as Harman International, a division of Samsung, LG Electronics, Klipsch, Bang & Olufsen, Xbox, a subsidiary of Microsoft, and others, Summit Wireless delivers seamless, dynamic audio experiences for high-definition content, including movies and video, music, sports, gaming/esports and more. Summit Wireless is a founding member of WiSA, the Wireless Speaker and Audio Association and works in joint partnership to champion the most reliable interoperability standards across the audio industry. Summit Wireless is headquartered in San Jose, Calif., with sales teams in Taiwan, China, Japan and Korea. For more information, visit the company's website at

Contact us: 212.418.1217